About Advanced Therapies
Advanced Therapies is a company based in Philadelphia (United States) founded in 1998 was acquired by Altaris in December 2024. Advanced Therapies operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Advanced Therapies, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Advanced Therapies
Unlock access to complete
Funding Insights of Advanced Therapies
Detailed funding history for Advanced Therapies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Advanced Therapies
Advanced Therapies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Altaris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm invests in the US
|
Locked | Locked | Locked |
Investor details for Advanced Therapies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advanced Therapies
Investment portfolio details for Advanced Therapies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Advanced Therapies
Detailed financials for Advanced Therapies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Advanced Therapies Comparisons
Peer comparison for Advanced Therapies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Advanced Therapies
Advanced Therapies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Precision fermentation services for biopharma and food are provided.
|
Detailed competitors of Advanced Therapies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Advanced Therapies
Complete news archive for Advanced Therapies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advanced Therapies
Advanced Therapies was founded in 1998.
Advanced Therapies is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Edward Hu is the current CEO of Advanced Therapies.
Advanced Therapies was established in 1998 as a contract manufacturer in the biopharmaceutical sector. Operations are based in Philadelphia, United States, where services focused on producing biopharmaceutical products are provided to clients. Expertise in manufacturing processes for advanced therapies is utilized to support various biopharma needs, including formulation and production under regulatory standards. The company is led by CEO Edward Hu.
Advanced Therapies's top competitors include KBI Biopharma, Aldevron and Ovagen.
Advanced Therapies has 1 investor. Key investors include Altaris.